Suppr超能文献

肾脏肿块的生长动力学:行主动监测的前瞻性队列患者分析。

Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance.

机构信息

Department of Urology, Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada.

出版信息

Eur Urol. 2011 May;59(5):863-7. doi: 10.1016/j.eururo.2011.02.023. Epub 2011 Feb 22.

Abstract

BACKGROUND

Active surveillance (AS) represents a treatment option for renal masses in patients who are not surgical candidates either because of existing comorbidities or patient choice. Among renal masses undergoing AS, some grow rapidly and require treatment or progress to metastatic disease. Patient and tumour characteristics related to this more aggressive behaviour have been poorly studied.

OBJECTIVE

To report the analysis of a multi-institutional cohort of patients undergoing AS for small renal masses.

DESIGN, SETTING, AND PARTICIPANTS: This prospective study included 82 patients with 84 renal masses who underwent AS in three Canadian institutions between July 2001 and June 2009.

INTERVENTION

All patients underwent AS for renal masses presumed to be renal cell carcinoma (RCC) as based on diagnostic imaging.

MEASUREMENTS

Age, sex, symptoms at presentation, maximum diameter at diagnosis (cm), tumour location (central/peripheral), degree of endophytic component (1-100%), and tumour consistency (solid/cystic) were used to develop a predictive model of the tumour growth rate using binary recursive partitioning analysis with a repeated measures outcome.

RESULTS AND LIMITATIONS

With a median follow-up of 36 mo (range: 6-96), the mean annual renal mass growth rate for the entire cohort was 0.25 cm/yr (standard deviation [SD]: 0.49 cm/yr). Only one patient (1.2%) developed metastatic RCC. Amongst all variables, maximum diameter at diagnosis was the only predictor of tumour growth rate, and two distinct growth rates were identified. Masses that are ≥2.45 cm in largest diameter at diagnosis grow faster than smaller masses. This series was limited by its moderate sample size, although it is the largest published prospective series to date.

CONCLUSIONS

We confirm that most renal masses grow slowly and carry a low metastatic potential. Tumour size is a predictor of tumour growth rate, with renal masses <2.45 cm growing more slowly than masses >2.45 cm.

摘要

背景

主动监测(AS)是一种治疗选择,适用于因现有合并症或患者选择而不适合手术的肾肿瘤患者。在接受 AS 的肾肿瘤中,有些肿瘤生长迅速,需要治疗或进展为转移性疾病。与这种更具侵袭性行为相关的患者和肿瘤特征尚未得到充分研究。

目的

报告对在加拿大三个机构接受 AS 治疗的小肾肿瘤患者的多机构队列进行的分析。

设计、设置和参与者:这项前瞻性研究纳入了 2001 年 7 月至 2009 年 6 月期间在加拿大三个机构接受 AS 治疗的 82 例 84 个肾肿瘤患者。

干预

所有患者均因诊断影像学提示肾细胞癌(RCC)而接受 AS 治疗。

测量

年龄、性别、就诊时的症状、诊断时的最大直径(cm)、肿瘤位置(中央/外周)、内生长成分的程度(1-100%)和肿瘤一致性(实性/囊性)用于使用二元递归分割分析建立肿瘤生长率预测模型,该模型具有重复测量结果。

结果和局限性

中位随访 36 个月(范围:6-96 个月),整个队列的平均每年肾肿瘤生长速度为 0.25 cm/yr(标准差 [SD]:0.49 cm/yr)。只有 1 例(1.2%)患者发生转移性 RCC。在所有变量中,诊断时的最大直径是肿瘤生长率的唯一预测因素,确定了两种不同的生长速度。诊断时最大直径≥2.45 cm 的肿瘤生长速度快于较小的肿瘤。该系列的局限性在于其中等样本量,尽管它是迄今为止发表的最大的前瞻性系列。

结论

我们证实,大多数肾肿瘤生长缓慢,转移潜能低。肿瘤大小是肿瘤生长速度的预测因素,直径<2.45 cm 的肾肿瘤比直径>2.45 cm 的肿瘤生长速度慢。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验